Atlas Trials

Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

Clinical trial NCT07617610 · RECRUITING

Trial details

NCT number
NCT07617610
Sponsor
Swiss Cancer Institute
Status
RECRUITING
Study type
OBSERVATIONAL
Metastatic Colorectal CancerBRAF V600E Mutation
Start date
2025-05-25
Primary completion
2030-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.